title: Bevacizumab and cancer treatment-related mortality.
authors.forename: Zu-Yao
authors.initials: ZY
authors.lastname: Yang
authors.forename: Chen
authors.initials: C
authors.lastname: Mao
authors.forename: Jin-Ling
authors.initials: JL
authors.lastname: Tang
mesh_terms: D020533:Angiogenesis Inhibitors / Q000009:adverse effects*; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D003627:Data Interpretation, Statistical; D018450:Disease Progression; D006801:Humans; D015201:Meta-Analysis as Topic; D009026:Mortality; D009369:Neoplasms / Q000188:drug therapy*
chemical_list: D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab